| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide Free | NBP2-27224 | |||
| Azide Free | NBP2-27224SS | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX1306A488 | |||
| Alexa Fluor 546 | DDX1306A546 | |||
| Alexa Fluor 647 | DDX1306A647 | |||
| Biotin | DDX1306B | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX1305A488 | |||
| Alexa Fluor 546 | DDX1305A546 | |||
| Alexa Fluor 647 | DDX1305A647 | |||
| Biotin | DDX1305B | |||
![Western Blot: TNF-alpha Antibody (6N1E7) [NBP2-27223] - Analysis using Azide Free version of NBP2-27223. TNF alpha recombinant protein using TNF alpha antibody at 3 ug/mL. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-6N1E7-Western-Blot-NBP2-27223-img0004.jpg "Western Blot: TNF-alpha Antibody (6N1E7) [NBP2-27223] - Analysis using Azide Free version of NBP2-27223. TNF alpha recombinant protein using TNF alpha antibody at 3 ug/mL. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![<b>Biological Strategies Validation. </b>Flow Cytometry: TNF-alpha Antibody (6N1E7) [NBP2-27223] - Human PBMC were stimulated with PMA (10 ng/mL) and Ionomycin (500 ng/mL) for 5h in presence of Brefeldin A. At the end of stimulation, cells were surface stained before testing by intracellular staining. Fixed and permeabilized cells were incubated with 10 uL (0.5 ug) of TNF- alpha antibody for 30 minutes on ice. Lymphocyte population was gated for analysis to show TNF alpha positive T cells.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-6N1E7-Flow-Cytometry-NBP2-27223-img0002.jpg)
![Inhibition Activity: TNF-alpha Antibody (6N1E7) [NBP2-27223] - Validation of inhibitory effects of TNF alpha antibody on TNF alpha activity in the cell line. NF-kB/SEAPorter cells were plated in 96-well plate at 5 x 10^4 cells per well for 16 h. Cells were pre-incubated with TNF alpha antibody at 10 and 20 ug/ml for 1 hr, then treated with 10 ng/ml TNF alpha or 10 ng/ml PMA. After 24h, the secreted alkaline phosphatase (SEAP) was analyzed using the SEAPorterAssay Kit . Image using the Azide Free format of this antibody.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-6N1E7-Inhibition-Activity-NBP2-27223-img0006.jpg)
![Western Blot: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - Analysis of a purified multi-epitopic HIV antigen. The expected length of the HIV protein is 20 kDa. The second signal might represent a by-product.](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-425D11-01-clone-3-Western-Blot-DDX1306-img0004.jpg "Western Blot: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - Analysis of a purified multi-epitopic HIV antigen. The expected length of the HIV protein is 20 kDa. The second signal might represent a by-product.")
![Flow Cytometry: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - FACS staining of HEK293-gp41TM cell line](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-425D11-01-clone-3-Flow-Cytometry-DDX1306-img0001.jpg)
![Inhibition Activity: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - Inhibition of HR1/HR2 fusion complex formation](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-425D11-01-clone-3-Inhibition-Activity-DDX1306-img0002.jpg)
![Neutralization: HIV-1 gp41 Antibody (425D11.01/ clone 3) [DDX1306] - Neutralizing activities on laboratory strains and primary HIV-1 strains](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-425D11-01-clone-3-Neutralization-DDX1306-img0003.jpg)
![Flow Cytometry: HIV-1 gp41 Antibody (417D3.08/ clone 2) [DDX1305] - FACS staining of HEK293-gp41TM cell line](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-417D3-08-clone-2-Flow-Cytometry-DDX1305-img0001.jpg "Flow Cytometry: HIV-1 gp41 Antibody (417D3.08/ clone 2) [DDX1305] - FACS staining of HEK293-gp41TM cell line")
![Inhibition Activity: HIV-1 gp41 Antibody (417D3.08/ clone 2) [DDX1305] - Inhibition of HR1/HR2 fusion complex formation](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-417D3-08-clone-2-Inhibition-Activity-DDX1305-img0002.jpg)
![Neutralization: HIV-1 gp41 Antibody (417D3.08/ clone 2) [DDX1305] - Neutralizing activities on laboratory strains and primaryHIV-1 strains](http://images.novusbio.com/fullsize/HIV-1-gp41-Antibody-417D3-08-clone-2-Neutralization-DDX1305-img0003.jpg)